Actively Recruiting

Phase 3
Age: 40Years - 80Years
All Genders
NCT06474039

The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD

Led by Mahidol University · Updated on 2025-05-06

50

Participants Needed

1

Research Sites

113 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to demonstrate the effects of triple therapy (ICS/LABA/LAMA) and dual bronchodilators (LAMA/LABA) on air trapping in the lungs' COPD patients and inflammatory mediators

CONDITIONS

Official Title

The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD

Who Can Participate

Age: 40Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients who have met the criteria for COPD GOLD B defined by an exacerbation not more than 1 time in the last year prior to the study enrollment. These patients will be recruited in sequential sequence.
  • Patients with COPD GOLD B are previously treated with either LAMA or LAMA/LABA or short-acting bronchodilators
  • Patients who are able to provide informed consent.
Not Eligible

You will not qualify if you...

  • Concomitant with active and old pulmonary TB, lung cancer, bronchiectasis, lung fibrosis, destroyed lung, other malignancy, active heart diseases.
  • Receiving long-term treatment with immunosuppressive drugs and systemic corticosteroids
  • Being treated with triple therapy (ICS/LABA/LAMA)
  • Being in terminally ill conditions

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Division of Respiratory Disease and TB, Siriraj Hospital

Bangkoknoi, BKK, Thailand, 10700

Actively Recruiting

Loading map...

Research Team

K

kittipong maneechotesuwan, MD, PhD.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here